Bruker Corporation
$41.1
▲
1.88%
2026-04-21 05:47:00
www.bruker.com
NMS: BRKR
Explore Bruker Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$6.23 B
Current Price
$41.1
52W High / Low
$56.22 / $28.53
Stock P/E
—
Book Value
$16.15
Dividend Yield
0.49%
ROCE
4.76%
ROE
-0.38%
Face Value
—
EPS
$-0.15
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
11,085
Beta
1.2
Debt / Equity
81.38
Current Ratio
1.73
Quick Ratio
0.87
Forward P/E
15.55
Price / Sales
1.67
Enterprise Value
$7.52 B
EV / EBITDA
15.04
EV / Revenue
2.19
Rating
Buy
Target Price
$47.86
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
- Meaningful dividend yield is available.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Medtronic plc | $83.14 | 23.25 | $107.11 B | 3.34% | 8.3% | 9.39% | $106.33 / $79.93 | $38.17 |
| 2. | TransMedics Group, Inc. | $113.13 | 20.39 | $3.88 B | — | 11.09% | 54.24% | $156 / $84.53 | $13.81 |
| 3. | enVVeno Medical Corporation | $12.08 | — | $7.92 M | — | -76.16% | -56.21% | $196.7 / $8.67 | $41.36 |
| 4. | HeartSciences Inc. | $2.05 | — | $6.85 M | — | -1607.2% | -3.82% | $6.47 / $1.89 | $0.83 |
| 5. | Globus Medical, Inc. | $96.1 | 24.49 | $13.01 B | — | 11.18% | 12.29% | $101.4 / $51.79 | $33.86 |
| 6. | Orthofix Medical Inc. | $12.65 | — | $507.83 M | — | -12.14% | -19.34% | $16.99 / $10.24 | $11.3 |
| 7. | Electromed, Inc. | $25.4 | 23.98 | $215.65 M | — | 22.29% | 20.2% | $30.73 / $17.73 | $5.49 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 977.2 M | 860.5 M | 797.4 M | 801.4 M | 979.6 M | — |
| Operating Profit | 111.8 M | 35 M | 26.3 M | 65.7 M | 157 M | — |
| Net Profit | 26 M | -59.6 M | 7.6 M | 17.4 M | 13.7 M | — |
| EPS in Rs | 0.17 | -0.39 | 0.05 | 0.11 | 0.09 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 3.44 B | 3.37 B | 2.96 B | 2.53 B |
| Operating Profit | 236 M | 379.2 M | 489.1 M | 462.4 M |
| Net Profit | -8.6 M | 113.1 M | 427.2 M | 296.6 M |
| EPS in Rs | -0.06 | 0.74 | 2.81 | 1.95 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 6.24 B | 5.81 B | 4.25 B | 3.61 B |
| Total Liabilities | 3.73 B | 3.99 B | 2.84 B | 2.48 B |
| Equity | 2.46 B | 1.78 B | 1.38 B | 1.11 B |
| Current Assets | 2.21 B | 2.05 B | 2.16 B | 2.11 B |
| Current Liabilities | 1.28 B | 1.28 B | 1.2 B | 914.3 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 134.1 M | 251.3 M | 350.1 M | 274.4 M |
| Investing CF | -196.5 M | -1.76 B | -326 M | -251.6 M |
| Financing CF | 135.1 M | 1.23 B | -193.4 M | -415.3 M |
| Free CF | 13.9 M | 136 M | 243.2 M | 145.2 M |
| Capex | -120.2 M | -115.3 M | -106.9 M | -129.2 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 13.56% | 17.14% | — | — |
| Earnings Growth % | -73.53% | 44.03% | — | — |
| Profit Margin % | 3.36% | 14.41% | 11.72% | — |
| Operating Margin % | 11.26% | 16.5% | 18.27% | — |
| Gross Margin % | 49% | 51.05% | 51.59% | — |
| EBITDA Margin % | 13.03% | 22.79% | 20.5% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-23 | $0.05 |
| 2025-12-08 | $0.05 |
| 2025-09-23 | $0.05 |
| 2025-06-16 | $0.05 |
| 2025-03-17 | $0.05 |
Stock Splits
No stock split history available.